In Study 041, Translarna showed a significant improvement in six key study endpoints compared with placebo after 72 weeks. The Food and Drug Administration (FDA) has accepted for review the ...
Non-disclosure agreements (NDAs) are widespread in the business world. They restrict employees from potentially damaging an organization by releasing trade secrets and confidential information or ...
Immunome is advancing varegacestat for desmoid tumors, targeting NDA submission in Q2 2026 after positive phase 3 RINGSIDE ...
In nearly every business transaction, some degree of confidential information is exchanged. Whether it involves financial data, a client list, proprietary code or strategic plans, that information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results